Kallikrein 5, Human, Recombinant, Carrier-free

データシート

• 商品コード：1108-SE-010
• メーカー：RSD
• 包装：10μg
• 価格： ¥86,000
• 在庫：無(発注済)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Blaber SI et al. The autolytic regulation of human kallikrein-related peptidase 6. Biochemistry 2007 May;46(17):5209-17
  Blaber SI et al
  2007/01/01
  
• 備考：
  Species: Human, Application: Bioassay, Sample type: Peptide (pro-KLK6)
• 参照：
  

• No.： 2
• 文献情報：
  Yamasaki K et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med. 2007 Aug;13(8):975-80
  Yamasaki K et al
  2007/01/01
  
• 備考：
  Species: Mouse, Application: In Vivo
• 参照：
  

• No.： 3
• 文献情報：
  Mukai S et al. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases. FEBS J. 2008 Mar;275(5):1003-17
  Mukai S et al
  2008/01/01
  
• 備考：
  Species: Mouse, Application: Enzyme Activity, Sample type: enzyme solution
• 参照：
  

• No.： 4
• 文献情報：
  Meyer-Hoffert U et al. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor. PLoS ONE 2009;4(2):e4372
  Meyer-Hoffert U et al
  2009/01/01
  
• 備考：
  Application: Enzyme Activity, Sample Type: N/A
• 参照：
  

• No.： 5
• 文献情報：
  Briot A et al. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J. Exp. Med. 2009 May;206(5):1135-47
  Briot A et al
  2009/01/01
  
• 備考：
  Application: ELISA Standard, Sample Type: Cell Supernate
• 参照：
  

• No.： 6
• 文献情報：
  Sexton DJ et al. Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases. Biochem. J. 2009 Sep;422(2):383-92
  Sexton DJ et al
  2009/01/01
  
• 備考：
  Application: Biacore binding study, Sample Type: antibody
• 参照：
  

• No.： 7
• 文献情報：
  Morizane S et al. Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid. J. Invest. Dermatol. 2010 May;130(5):1297-306
  Morizane S et al
  2010/01/01
  
• 備考：
  Application: ELISA Standard, Sample Type: Cell Supernates
• 参照：
  

• No.： 8
• 文献情報：
  Sales KU et al. Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome. Nat. Genet. 2010 Aug;42(8):676-83
  Sales KU et al
  2010/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Other: His-tagged pro-KLK5,Other: His-tagged pro-KLK7
• 参照：
  

• No.： 9
• 文献情報：
  Meyer-Hoffert U et al. Isolation of SPINK6 in human skin: selective inhibitor of kallikrein-related peptidases. J. Biol. Chem. 2010 Oct;285(42):32174-81
  Meyer-Hoffert U et al
  2010/01/01
  
• 備考：
  Application: Enzyme Assay, Sample Type: Peptide Substrate
• 参照：
  

• No.： 10
• 文献情報：
  Yamamoto-Tanaka M et al. Mesotrypsin and caspase-14 participate in prosaposin processing: potential relevance to epidermal permeability barrier formation. J. Biol. Chem. 2014 Jul;289(29):20026-38
  Yamamoto-Tanaka M et al
  2014/01/01
  
• 備考：
  Application: Bioassay, Sample Type: Cell culture
• 参照：
  

• No.： 11
• 文献情報：
  Fischer J et al. Cross-linking of SPINK6 by transglutaminases protects from epidermal proteases. J. Invest. Dermatol. 2013 May;133(5):1170-7
  Fischer J et al
  2013/01/01
  
• 備考：
  Application: Bioassay, Sample Type: protein
• 参照：
  

• No.： 12
• 文献情報：
  Fortugno P et al. Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis. J. Invest. Dermatol. 2011 Nov;131(11):2223-32
  Fortugno P et al
  2011/01/01
  
• 備考：
  Application: Enzyme Activity, Sample Type: Substrate
• 参照：
  

• No.： 13
• 文献情報：
  Zhang L et al. Defects in Stratum Corneum Desquamation Are the Predominant Effect of Impaired ABCA12 Function in a Novel Mouse Model of Harlequin Ichthyosis. PLoS ONE 2016;11(8):e0161465
  Zhang L et al
  2016/01/01
  
• 備考：
  Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells
• 参照：
  

• No.： 14
• 文献情報：
  Straus MR et al. A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site. PLoS ONE 2017;12(3):e0174827
  Straus MR et al
  2017/01/01
  
• 備考：
  Application: Enzyme Activity, Sample Type: peptides
• 参照：